CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
<p>Triple-negative breast cancer (TNBC), which lacks estrogen receptor α (ERα), progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression, is closely related to basal-like breast cancer. Previously, we and others report that cyclin E/cyclin-dependent kinase 2 (CDK2)...
محفوظ في:
مواد مشابهة
-
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
حسب: Lei Nie (556344)
منشور في: (2020) -
Evaluation of Estrone Liposomes using Microfluidics for Breast Cancer Therapy
حسب: Al Bostami, Rouba D.
منشور في: (2023) -
Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis
حسب: Mukhopadhyay, Debasmita
منشور في: (2021) -
Estrogens and the risk of breast cancer: A narrative review of literature
حسب: Khayry Al-Shami (17863865)
منشور في: (2023) -
Ultrasound triggered release of Trastuzumab-conjugated immunoliposomes targeting breast cancer
حسب: Ahmed, Amal Elsadig Elamir
منشور في: (2018)